Bryan, Garnier & Co announces $275mn Galapagos IPO

15 May 2015

Bryan, Garnier & Co, the pan-European investment bank for growth companies, announced the successful USD 275 million Nasdaq IPO for Galapagos NV, a major European clinical-stage biotechnology company.

The new shares were placed in a concurrent public offering in the US through ADSs at a price of USD 42.05 and private placement in Europe at a price of 37 euros per share. It is the largest Nasdaq IPO of a European biotech and one of three largest biotech IPO ever in Europe or in the US.

Bryan, Garnier & Co acted as co-manager and sole European investment bank, alongside Morgan Stanley, Credit Suisse, Cowen and Company and Nomura.

Source: Dion Global Type: IPO Related

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Stocks

Mutual Funds

Investment tracking